Synergy Pharmaceuticals Announces Extension for Filing of Third Quarter Form 10-Q Due to Hurricane Sandy

[at noodls] – NEW YORK, Nov. 9, 2012 — Synergy Pharmaceuticals Inc. (Nasdaq:SGYP), a developer of new drugs to treat gastrointestinal disorders and diseases, announced today that, in accordance with applicable rules … more

View todays social media effects on SGYP

View the latest stocks trending across Twitter. Click to view dashboard